Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Regina Ortmann

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Chemmedchem|March 21, 2009
Structure-based optimization of aldose reductase inhibitors originating from virtual screeningMichael Eisenmann, Holger Steuber, Matthias Zentgraf, et al.
Chemmedchem|May 13, 2008
Studies addressing the importance of charge in the binding of fosmidomycin-like molecules to deoxyxylulosephosphate reductoisomeraseJohann Perruchon, Regina Ortmann, Mirko Altenkämper, et al.
International Journal of Antimicrobial Agents|July 5, 2011
Resistance of the Burkholderia cepacia complex to fosmidomycin and fosmidomycin derivativesAnne-Sophie Messiaen, Thomas Verbrugghen, Charlotte Declerck, et al.
European Journal of Medicinal Chemistry|February 25, 2011
2-Acylamino-5-chlorobenzophenones with enhanced selectivity towards malaria parasitesSwetlana Heinrich, Mirko Altenkämper, Benjamin Bechem, et al.
Virulence|June 5, 2016
FR-900098, an antimalarial development candidate that inhibits the non-mevalonate isoprenoid biosynthesis pathway, shows no evidence of acute toxicity and genotoxicityJochen Wiesner, Christina Ziemann, Martin Hintz, et al.
European Journal of Medicinal Chemistry|January 12, 2005
Non-thiol farnesyltransferase inhibitors: N-(4-aminoacylamino-3-benzoylphenyl)-3-[5-(4-nitrophenyl)-2 furyl]acrylic acid amides and their antimalarial activityKatja Kettler, Jochen Wiesner, Katrin Silber, et al.
Bioorganic & Medicinal Chemistry|December 26, 2007
Synthesis of beta- and gamma-oxa isosteres of fosmidomycin and FR900098 as antimalarial candidatesTimothy Haemers, Jochen Wiesner, Dirk Giessmann, et al.
Chemmedchem|May 13, 2008
Development of benzophenone-based farnesyltransferase inhibitors as novel antimalarialsKatja Kohring, Jochen Wiesner, Mirko Altenkämper, et al.
Journal of Medicinal Chemistry|November 11, 2005
Benzophenone-based farnesyltransferase inhibitors with high activity against Trypanosoma cruziMónica I Esteva, Katja Kettler, Cristina Maidana, et al.
Bioorganic & Medicinal Chemistry|October 13, 2009
Antimalarial and antitrypanosomal activity of a series of amide and sulfonamide derivatives of a 2,5-diaminobenzophenoneMirko Altenkämper, Benjamin Bechem, Johann Perruchon, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Chemmedchem|March 21, 2009
Structure-based optimization of aldose reductase inhibitors originating from virtual screeningMichael Eisenmann, Holger Steuber, Matthias Zentgraf, et al.
Chemmedchem|May 13, 2008
Studies addressing the importance of charge in the binding of fosmidomycin-like molecules to deoxyxylulosephosphate reductoisomeraseJohann Perruchon, Regina Ortmann, Mirko Altenkämper, et al.
International Journal of Antimicrobial Agents|July 5, 2011
Resistance of the Burkholderia cepacia complex to fosmidomycin and fosmidomycin derivativesAnne-Sophie Messiaen, Thomas Verbrugghen, Charlotte Declerck, et al.
European Journal of Medicinal Chemistry|February 25, 2011
2-Acylamino-5-chlorobenzophenones with enhanced selectivity towards malaria parasitesSwetlana Heinrich, Mirko Altenkämper, Benjamin Bechem, et al.
Virulence|June 5, 2016
FR-900098, an antimalarial development candidate that inhibits the non-mevalonate isoprenoid biosynthesis pathway, shows no evidence of acute toxicity and genotoxicityJochen Wiesner, Christina Ziemann, Martin Hintz, et al.
European Journal of Medicinal Chemistry|January 12, 2005
Non-thiol farnesyltransferase inhibitors: N-(4-aminoacylamino-3-benzoylphenyl)-3-[5-(4-nitrophenyl)-2 furyl]acrylic acid amides and their antimalarial activityKatja Kettler, Jochen Wiesner, Katrin Silber, et al.
Bioorganic & Medicinal Chemistry|December 26, 2007
Synthesis of beta- and gamma-oxa isosteres of fosmidomycin and FR900098 as antimalarial candidatesTimothy Haemers, Jochen Wiesner, Dirk Giessmann, et al.
Chemmedchem|May 13, 2008
Development of benzophenone-based farnesyltransferase inhibitors as novel antimalarialsKatja Kohring, Jochen Wiesner, Mirko Altenkämper, et al.
Journal of Medicinal Chemistry|November 11, 2005
Benzophenone-based farnesyltransferase inhibitors with high activity against Trypanosoma cruziMónica I Esteva, Katja Kettler, Cristina Maidana, et al.
Bioorganic & Medicinal Chemistry|October 13, 2009
Antimalarial and antitrypanosomal activity of a series of amide and sulfonamide derivatives of a 2,5-diaminobenzophenoneMirko Altenkämper, Benjamin Bechem, Johann Perruchon, et al.
Pageof 2